By Joanna S. Cabredo

Inclisiran, a new life-saving treatment that can control cholesterol levels will be made available to patients suffering from heart diseases. The National Health Service, a government-funded service that provides free medical treatment in United Kingdom recently announced that thousands of patients have full access to the ground-breaking drug.

Study shows that heart disease is the world’s biggest killer with 140,000 people dying from the condition each year.

High levels of LDL-C makes people more likely to suffer a heart attack or stroke. Inclisiran lowers the level of a type of fatty substance called LDL-C found in the blood. The cholesterol-lowering treatment uses RNA interference (RNAi) to boost the liver’s ability to remove harmful cholesterol from the blood. After an initial dose, the drug will be given again after three months and then twice a year.

It has been estimated that Inclisiran could prevent 55,000 heart attacks and strokes, saving 30,000 lives within the next decade.

The cutting-edge treatment is said to save and improve patients’ lives.